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In Brief
Loss of the genome maintenance factor
Elg1 causes serious genome instability.
Johnson et al. find that PCNA unloading
by Elg1 is critical for genome
maintenance, and that PCNA retention on
DNA into G2/M phase causes genome
instability in cells lacking Elg1.
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Loss of the genome maintenance factor Elg1 causes
serious genome instability that leads to cancer, but
the underlying mechanism is unknown. Elg1 forms
the major subunit of a replication factor C-like com-
plex, Elg1-RLC, which unloads the ring-shaped poly-
merase clamp PCNA from DNA during replication.
Here, we show that prolonged retention of PCNA on
DNA into G2/M phase is the major cause of genome
instability in elg1D yeast. Overexpression-induced
accumulation of PCNAonDNAcauses genome insta-
bility. Conversely, disassembly-pronePCNAmutants
that relieve PCNA accumulation rescue the genome
instability of elg1D cells. Covalent modifications to
the retained PCNA make only a minor contribution
to elg1D genome instability. By engineering cell-cy-
cle-regulated ELG1 alleles, we show that abnormal
accumulation of PCNA on DNA during S phase
causesmoderate genome instability and its retention
throughG2/Mphase exacerbates genome instability.
Our results reveal that PCNA unloading by Elg1-RLC
is critical for genome maintenance.
INTRODUCTION
Maintenance of the genome is crucial for all living organisms
since loss of genome stability leads to mutations and chromo-
some rearrangements, causing cancers and other life-threat-
ening diseases (Aguilera and Go´mez-Gonza´lez, 2008; Negrini
et al., 2010). Cells deploy multiple mechanisms to prevent
genome instability, including error-free replication of the genome
in S phase, efficient repair of DNA damage, and faithful transmis-
sion of the genome to daughter cells. Loss of factors involved in
these processes generally causes profound genome instability
(Mailand et al., 2013; Negrini et al., 2010).
Elg1, themajor subunit of a replication factor C-like complex, is
critical for genome maintenance. In budding yeast, loss of the
ELG1 gene causes gross chromosomal rearrangements,
increased sister chromatid recombination, defective sister chro-
matid cohesion, derailed telomere length maintenance, and
sensitivity to the DNA alkylating drug methyl methanesulfonate
(MMS) (Banerjee andMyung, 2004; Bellaoui et al., 2003; Ben-Ar-684 Cell Reports 16, 684–695, July 19, 2016 ª 2016 The Author(s).
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2009; Parnas et al., 2009; Smolikov et al., 2004). The requirement
for Elg1 in genome maintenance is conserved in higher eukary-
otes, sincemicewith reducedexpression ofATAD5 (themamma-
lian ortholog of Elg1) exhibit genome instability and have a high
tumor incidence (Bell et al., 2011). In humans, somatic mutations
in ATAD5 have been found in primary endometrial tumors (Bell
et al., 2011). ATAD5 was moreover recently identified as a sus-
ceptibility locus for invasive epithelial ovarian cancer (Kuchen-
baecker et al., 2015). Despite its evident importance, themecha-
nism by which Elg1 ensures genome integrity is unknown.
One molecular function of yeast Elg1 Replication factor C-like
complex (Elg1-RLC) is to unload the proliferating cell nuclear an-
tigen (PCNA) sliding clamp from DNA during replication (Kubota
et al., 2013b; Ulrich, 2013). PCNA has a central role in DNA repli-
cation, repair, and chromatin dynamics, as illustrated by a muta-
tion in human PCNA associated with DNA repair deficiency syn-
drome akin to diseases like xeroderma pigmentosum, Cockayne
syndrome, and ataxia telangiectasia (Baple et al., 2014; Duffy
et al., 2016). PCNA is a ring-shaped homotrimeric complex
that encircles DNA to act as a sliding clamp, ensuring processiv-
ity of DNA polymerases. It also operates as a platform for recruit-
ment of numerous other proteins involved in DNA replication,
DNA repair and chromatin structure and assembly (Moldovan
et al., 2007). During DNA replication, Replication Factor C
(RFC) must load PCNA at the initiation of synthesis of each Oka-
zaki fragment. The hetero-pentameric RFC complex, composed
of largest subunit Rfc1 and smaller subunits Rfc2, 3, 4, and 5,
loads PCNA at primer-template junctions (Bowman et al.,
2004; Gomes and Burgers, 2001; Kelch et al., 2011). After
completion of each Okazaki fragment, PCNA must be unloaded
from DNA and is believed to be recycled to promote subsequent
Okazaki fragment synthesis. Previous findings indicate that the
Elg1-RLC, which comprises the Elg1 subunit associated with
the Rfc2–5 subunits, functions to unload PCNA during replica-
tion (Kubota et al., 2013a, 2013b). This replication-coupled
PCNA unloading by Elg1-RLC occurs genome-wide (as opposed
to at specific loci) and requires prior Okazaki fragment ligation
(Kubota et al., 2015). The role of the Elg1-RLC in PCNA unloading
appears to be conserved in humans, since ATAD5 is required for
proper removal of PCNA from chromatin in human cell lines (Lee
et al., 2013; Shiomi and Nishitani, 2013).
PCNA can bemodified by ubiquitin and small ubiquitin-related
modifier (SUMO), modulating its physical interactions with
various binding partners. PCNA ubiquitination at K164 is inducedcommons.org/licenses/by/4.0/).
by replication stress associated with fork stalling (Davies et al.,
2008; Hoege et al., 2002). K164 mono-ubiquitinated PCNA me-
diates an error-prone DNA damage tolerance pathway by re-
cruiting translesion synthesis polymerases that can replicate
past a DNA lesion (Bienko et al., 2005; Stelter and Ulrich,
2003). K164 poly-ubiquitinated PCNA in contrastmediates an er-
ror-free mode of damage bypass that involves template switch
recombination using the sister chromatid (Hoege et al., 2002;
Parker and Ulrich, 2009; Stelter and Ulrich, 2003). In budding
yeast, SUMOylation of PCNA at K164 and K127 is stimulated
simply by DNA association and occurs during S phase without
exogenous DNA damage (Parker et al., 2008). One role for
PCNA SUMOylation is to prevent inappropriate recombination
through recruitment of DNA helicase Srs2 that prevents forma-
tion of Rad51 filaments (Papouli et al., 2005; Pfander et al.,
2005). Budding yeast Elg1-RLC preferentially interacts with
SUMOylated PCNA through three SUMO-interacting motifs
(SIMs) (Parnas et al., 2010). SUMOylation may assist but is not
necessary for PCNA unloading (Kubota et al., 2013b), and the
importance of the SUMO binding activity of Elg1 for PCNA un-
loading is not yet fully understood.
The Elg1-RLC is thought to function in processes other than
PCNA unloading. Yeast Elg1 can interact with several additional
proteins—including SUMOylated proteins, SUMO-processing
proteins, and the SUMO-like domain protein Esc2—mediated
by the N-terminal region of Elg1 which contains the SIMs (Parnas
et al., 2011; Urulangodi et al., 2015).
It is unknown whether the dramatic genome instability that oc-
curs in the absence of Elg1 is caused by failure of PCNA unload-
ing, or instead by the loss of interaction with other Elg1 binding
partners. Here, we address this issue, and our results reveal
that aberrant retention and accumulation of PCNA on DNA is
the major cause of genome instability in elg1D. We show that
overexpression of PCNAcauses its accumulation onDNA, result-
ing ingenome instability resembling that causedby theelg1Dmu-
tation. Relieving PCNA accumulation through the use of disas-
sembly-prone PCNA mutants results in rescue of all aspects of
the elg1D phenotype tested. To assess whether PCNA retention
is deleterious at a particular cell-cycle stage, we construct cell-
cycle-regulated alleles of ELG1. Analysis of their impact shows
that abnormal PCNA retention on DNA beyond DNA replication
and into G2/M phase is the root cause of genome instability.
RESULTS
ELG1 Truncation Mutants Causing PCNA Accumulation
on Chromatin Exhibit Increased Sensitivity to MMS
Impaired Elg1 function causes sensitivity to MMS (Davidson and
Brown, 2008). We first tested whether there is a correlation be-
tweenMMS sensitivity and failure of Elg1 to unload PCNA. Either
full-length or various mutant forms of Elg1 were expressed from
plasmids in an elg1D background (Davidson and Brown, 2008)
(Figure 1A). Their ability to unload PCNA was quantified by as-
sessing PCNA present in chromatin fractions and using western
blots of whole-cell extracts (where SUMO-PCNA acts as a proxy
for the PCNA pool that is chromatin bound). As expected, Elg1
truncations unable to form a complex with other RFC subunits
(Davidson and Brown, 2008) were generally defective in unload-ing PCNA from chromatin (Figure 1B). Interestingly, the levels of
PCNA accumulation on chromatin caused by these ELG1 trun-
cation mutants largely correlate with increased sensitivity to
MMS (Figures 1B and 1C). In particular, the N-terminal domain
of Elg1, which contains the SUMO-interacting motifs (SIMs), is
not essential for MMS resistance and PCNA unloading (Figures
1B and 1C, 216–791)—despite its importance for mediating
interaction with SUMOylated proteins (Parnas et al., 2011).
This observation that MMS sensitivity generally mirrors failure
of PCNA unloading led us to design further experiments aimed
at examining whether PCNA hyper-accumulation on DNA is in
fact the major cause of the MMS sensitivity and other defects
observed in an elg1D mutant.
Overexpression of PCNA Causes Its Accumulation on
Chromatin and Exacerbates Phenotypes of elg1D
We envisaged two general mechanisms through which failed
PCNA unloading in the absence of Elg1 might cause genome
instability. Genome instability might be due to PCNA accumula-
tion on DNA that interferes with subsequent chromosome trans-
actions, or else due to a shortage of PCNAat sites of DNA synthe-
sis caused by delayed recycling of PCNA as a consequence of
failed unloading. Partly to differentiate between these models,
we examined effects of overexpressing PCNA. In the latter
case, genome instability of elg1Dwould be rescued by supplying
excess PCNA during overexpression. We constructed strains
where thePOL30gene (encodingPCNA inbudding yeast) is fused
to a galactose-inducible promoter (GAL-POL30) and integrated in
the genome, so that PCNA overexpression can be induced by
galactose addition. Even in the presence of the PCNA unloader
Elg1, overexpressing PCNA caused some accumulation on
DNA (Figure 2A, lanes 1 and 2; Figure S1). We also found that
overexpressing PCNA in an ELG1+ background sensitizes cells
to MMS (Figure 2B), consistent with excess PCNA on chromatin
causing the increased MMS sensitivity. Supporting this idea,
overexpressing PCNA in the absence of Elg1 results in hyper-
accumulation of PCNA on chromatin (Figure 2A, lanes 3 and 4;
Figure S1), and extreme sensitivity to MMS (Figure 2B). We also
observed that, even without MMS, growth of the elg1D mutant
strains is impaired when PCNA is overexpressed (Figure 2B, no
MMS, Gal). These results support the idea that increased sensi-
tivity to MMS of elg1D is caused by PCNA accumulation on chro-
matin, rather than by a shortage of PCNA at replication forks.
Loss of the PCNA unloader Elg1 causes elevated levels of sis-
ter chromatid recombination, indicative of genome instability
(Kanellis et al., 2003). We next tested whether PCNA accumula-
tion on DNA induced by its overexpression causes increased sis-
ter chromatid recombination. We used strains in which two tan-
dem fragments of the HIS3 gene are integrated upstream of the
TRP1 locus; one fragment lacks the 50 region (his3D50) and the
other lacks the 30 region (his3D30), with each fragment containing
around 300 bp of identical sequence in the central region of the
gene (Fasullo and Davis, 1987) (Figure 2B, top). These strains
lack endogenous HIS3, so that a functional HIS3 gene can only
be generated via inter-sister-chromatid recombination. We
observed that PCNA overexpression caused a slight increase
of spontaneous sister chromatid recombination rate in the
presence of Elg1, which was greatly exacerbated in the absenceCell Reports 16, 684–695, July 19, 2016 685
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Figure 1. Cells Showing PCNA Accumulation on Chromatin Caused
by Truncation of ELG1 Exhibit Increased Sensitivity to MMS
(A) Schematic structure of Elg1 and truncated mutants. Interaction of trun-
cated Elg1 with Rfc4 (RFC formation) was examined previously (Davidson and
Brown, 2008). NLS, nuclear localization signal; SIMs, SUMO interactingmotifs;
PIP-like, PCNA interacting peptide-like motif.
(B) Accumulation of SUMO-PCNA in whole-cell extracts and PCNA on chro-
matin in cells expressing truncated Elg1 fragments. Whole-cell extracts (WCE)
and chromatin-enriched fractions (Ch) were prepared from elg1D cells, car-
rying the empty plasmid or plasmids containing truncated alleles of ELG1, in
log phase. Truncated Elg1 and PCNA were detected by western blotting.
Percentage of cells with small buds, indicative of cells in S phase, is shown
below blots. Quantification of average of two experiments was shown. Error
bars, SDs.
(C) Sensitivity to MMS of elg1D cells carrying the empty plasmid or plasmids
containing truncated alleles of ELG1. 5-fold serial dilutions of cells were
spotted on synthetic medium lacking leucine with 2% glucose, plus or minus
MMS, and incubated for 3–4 days at 30C.
See also Figure S4.
686 Cell Reports 16, 684–695, July 19, 2016of Elg1 (Figure 2C, bottom). These results are consistent
with the idea that as with MMS sensitivity, increased sister chro-
matid recombination in elg1D is caused by PCNA accumulation
on DNA.
Disassembly-Prone PCNA Mutants Rescue MMS
Sensitivity of elg1D
If the phenotypes of elg1D are caused by PCNA accumulation,
then removal of PCNA from DNA should rescue the phenotypes.
To relieve the accumulation of PCNA on DNA caused by ELG1
deletion, we utilized PCNA mutants that in vitro cannot form sta-
ble trimers due to point mutations at the trimer interface (C81R,
E143K, and D150E; Figure 3A, red) (Dieckman et al., 2013; Goell-
ner et al., 2014; Lau et al., 2002). We first tested the effects of
these trimer interface mutants in vivo and found that all three
mutations prevent accumulation of PCNA on chromatin in the
absence of Elg1 (Figure 3B), consistent with their spontaneous
dissociation from DNA due to trimer instability. Although their
markedly reduced chromatin association indicates that these
PCNA mutants dissociate prematurely from DNA, cells express-
ing the mutants show no obvious growth defect at 30C in the
absence of MMS (Figure 3C, no MMS plates) (see Discussion).
We then examined whether disassembly-prone PCNA mu-
tants rescue the sensitivity of elg1D to MMS. Remarkably, the
increased MMS sensitivity caused by the elg1D mutation was
rescued by the disassembly-prone PCNA alleles E143K and
D150E (Figure 3C). Although the disassembly-prone C81Rmuta-
tion itself sensitized cells to MMS, deletion of ELG1 in the C81R
mutant likewise did not cause furtherMMSsensitivity (Figure 3C).
In fact, this characteristic is shared by all trimer interfacemutants
tested (Figures S2A–S2C), including S152P, V180D, and the
S115P mutant (also known as pol30–52) (Ayyagari et al., 1995;
Goellner et al., 2014). Among these, the lack of accumulation
of the S115P mutant on chromatin has been confirmed (Fig-
ure S2B). These results strongly suggest that theMMS sensitivity
associated with loss of Elg1 is a consequence of hyper-accumu-
lation of PCNA on DNA. The differential MMS sensitivity of indi-
vidual disassembly-prone PCNA mutants is likely due to differ-
ences in the nature of the mutations and how they affect trimer
stability or recruitment of additional factors by PCNA.
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Figure 2. Overexpression of PCNA Causes Its Accumulation on Chromatin and Exacerbates Phenotypes of elg1D
(A) Overexpression of PCNA causes its accumulation on chromatin in ELG1+ and exacerbates PCNA accumulation on chromatin in elg1D. Cells were arrested in
G1 phase by alpha-factor, and PCNA overexpression was induced for 2 hr by adding galactose prior to releasing into S phase. Cells were then collected at mid-S
phase (35min after release) andwhole-cell extract and chromatin-enriched fractionswere prepared. PCNA levels were examined bywestern blotting (left panels).
Quantitation of total PCNA including both unmodified and modified PCNA (normalized to histone H3) is shown, relative to ELG1+ with empty vector (right panels
and see also Figure S1). The POL30 gene encodes PCNA.
(B) Overexpression of PCNA sensitizes ELG1+ and elg1D cells to MMS and causes slow growth of elg1D. 5-fold serial dilutions of ELG1+ or elg1D carrying the
GALp plasmid (empty) or GALp-POL30 plasmid (POL30) integrated in the genome were spotted on synthetic medium (without histidine) with 2% glucose (Glu;
uninduced) or 2% galactose + 2% raffinose (Gal; induced), plus or minus MMS. Plates were incubated for 3–4 days at 30C.
(C) Spontaneous sister chromatid recombination assay. The sister chromatid recombination substrate (top) is composed of one 50 and one 30 deletion fragment of
theHIS3 gene, inserted at the TRP1 locus. Formation of a functionalHIS3 gene only occurs via sister chromatid recombination (either reciprocal recombination or
gene conversion) between theHIS3 deletion fragments that possess a region of overlap (black region). Spontaneous sister chromatid recombination rate (bottom)
was calculated as described in Experimental Procedures. Fold increase over wild-type is shown above. Error bars, 95% confidence intervals. Mann-Whitney;
***p value <0.0001; *p value <0.05.
See also Figure S1.Disassembly-Prone PCNA Mutants Rescue the
Increased Sister Chromatid Recombination and
Abnormal Elongation of Telomeres of elg1D
We next tested whether the increased sister chromatid
recombination and abnormal elongation of telomeres observed
in elg1D are rescued by relieving accumulation of PCNA on
DNA. Deletion of ELG1 caused an 3-fold increase in sponta-neous sister chromatid recombination rate at the tester locus
(as illustrated in Figure 2C) that was largely rescued by the
disassembly-prone PCNA mutants D150E, E143K, and C81R
(Figure 3D). PCNA mutant D150E could not, however, rescue
elevated sister chromatid recombination rate caused by
absence of Sgs1, a RecQ family DNA helicase required for pro-
cessing recombination intermediates (Ashton and Hickson,Cell Reports 16, 684–695, July 19, 2016 687
2010; Kanellis et al., 2003) (Figure 3E). This control confirms that
sister chromatid recombination can still occur in a trimer insta-
bility mutant and indicates that it is indeed PCNA accumulation
on DNA that causes the elevated recombination levels seen in
elg1D.
Deletion of ELG1 results in telomere elongation that depends
on active telomerase (Smolikov et al., 2004). As with the
increased sister chromatid recombination, abnormal elongation
of telomeres in elg1D is rescued by disassembly-prone PCNA
mutants (Figure 3F). This observation indicates that PCNA
accumulation on DNA also deregulates telomere maintenance,
through a pathway as yet unknown.
Preventing PCNA Modification in elg1D Does Not
Rescue MMS Sensitivity or Increase Sister Chromatid
Recombination, but Partly Rescues Telomere
Elongation
PCNA modifications are believed to regulate cellular choice of
pathway for DNA repair or damage tolerance (Andersen et al.,
2008). We considered the possibility that hyper-accumulation
of the SUMOylated PCNA, as opposed to simply PCNA reten-
tion, could be the reason why elg1D cells show increased
MMS sensitivity. To address this issue, we tested whether pre-
venting PCNA SUMOylation rescues MMS sensitivity of elg1D.
We used a PCNA K127R mutant and simultaneously deleted
the SUMO E3 ligase SIZ1 whose product SUMOylates PCNA
at K164 (Parker et al., 2008). However, loss of SUMOylation
of PCNA (in this siz1D pol30-K127R strain) did not rescue
the MMS sensitivity of elg1D (Figure 4A). Preventing both
SUMOylation and ubiquitination of PCNA (using a pol30-
K127R&K164R allele) also failed to rescue the MMS sensitivity
of elg1D (Figure 4A). Note that such unmodifiable PCNAmutants
do still over-accumulate on DNA in elg1D (Kubota et al., 2013b).
These results indicate that the MMS sensitivity of elg1D can
result from accumulation of unmodified PCNA on DNA and is
not simply caused by over-recruitment of factors recognizing a
modified PCNA form.
Likewise, preventing PCNA modification did not rescue the
3-fold increase of sister chromatid recombination seen in
elg1D (Figure 4B), indicating that accumulation of unmodified
PCNA is sufficient to cause increased sister chromatid recom-
bination in elg1D.
We found that preventing PCNA modification can in contrast
partly rescue the abnormal telomere elongation in elg1D. Specif-
ically, in an elg1D background mutating K127, K164, or both res-
idues to non-modifiable arginine restores telomeres back closer
to normal length (Figure 4C). In contrast to the MMS sensitivity
and sister chromatid recombination, PCNA modification there-
fore appears to play a minor role in mediating elongation of telo-
meres in elg1D.
Establishing Cell-Cycle-Regulated Alleles that Restrict
Elg1 Activity to M/G1, S, or G2/M Phase
In the absence of Elg1, PCNA accumulates on DNA during
S phase and lingers abnormally on DNA at subsequent cell-cycle
stages (Kubota et al., 2013b). We considered whether it is critical
for genome stability that PCNA is removed from DNA by a
particular cell-cycle stage. To investigate this possibility, we688 Cell Reports 16, 684–695, July 19, 2016constructed cell-cycle-regulated alleles that restrict the pres-
ence of Elg1 to M/G1, S, or G2/M phase (Figure 5A) by taking
advantages of cell-cycle-regulated transcription and protein
degradation. Endogenous Elg1 protein is present throughout
the cell cycle (Figure 5Bi), and while it normally acts during
S phase it can still unload PCNA in G2 phase, after replication
is complete (Kubota et al., 2013b). To limit Elg1 activity to late
M/G1, the promoter and N-terminal degron domain of the CDK
inhibitor Sic1 (hereafter designated the ‘‘M/G1-tag’’) was inte-
grated upstream of the ELG1 gene, resulting in an M/G1-ELG1
fusion that expresses only in late M/G1 phase and whose prod-
uct is degraded in S phase (through phosphorylation-dependent
protein degradation [Sheaff and Roberts, 1996]). As expected,
M/G1-Elg1-6HAwas detectedmainly inM/G1phase (Figure 5Bii,
cell-cycle progression and stage confirmed by times of bud
emergence and Clb2 expression; Figures S3A and 5B). Similarly,
to limit the Elg1 protein to S phase, the promoter and N-terminal
degron element of the S phase cyclin Clb6 (‘‘S-tag’’) (Hombauer
et al., 2011) was fused to the ELG1 gene. Expression of full-
length S-Elg1-6HA is largely limited to S phase, although a
weaker band, probably corresponding to a degradation product
that lacks the S-tag, was detected throughout the cell cycle (Fig-
ure 5Biii). Finally, to limit Elg1 to G2/M phase, the promoter and
N-terminal region of the mitotic cyclin Clb2 including its degrons
(‘‘G2/M-tag’’) (Hombauer et al., 2011; Karras and Jentsch, 2010)
was integrated upstream of ELG1. G2/M-Elg1-6HA protein
was detected mainly in G2/M phase (Figure 5Biv), concurrent
with expression of endogenous Clb2. Although expressed from
different promoters, peak expression levels of M/G1-, S-, and
G2/M-Elg1 proteins were similar to that of endogenous Elg1
(Figure S3B).
We then quantified PCNA unloading when Elg1 is expressed
at defined stages of the cell cycle. In these experiments, levels
of SUMOylated PCNA in whole-cell extracts were used to
assess PCNA accumulation on DNA (since SUMOylation re-
flects chromatin-bound PCNA (Parker et al., 2008; Figures 1
and S3C). In wild-type cells, SUMO-PCNA was detected tran-
siently in S phase (Figures 5Bi and 5C), demonstrating that
PCNA is loaded during replication and unloaded once replica-
tion is finished. In S-ELG1 cells, we observed a similar pattern
of SUMO-PCNA appearance to that in wild-type cells although
the level of SUMO-PCNA in S-ELG1 cells is slightly increased
(Figures 5Biii and 5C), suggesting that S-tagged Elg1 can un-
load PCNA from DNA during replication, but its activity is slightly
impaired by the tagging. In the complete absence of Elg1,
SUMO-PCNA massively over-accumulated in S phase, and,
although levels gradually decreased, they still remained abnor-
mally high as cells entered the next S phase (Figures 5Bv and
5C), indicating that PCNA is retained on DNA even through
G2/M phase. PCNA retention on DNA through G2/M phase
was confirmed by western blot analysis of chromatin-enriched
fractions (Figure S3C). M/G1-ELG1 cells have an abnormal
SUMO-PCNA pattern resembling that of the elg1D mutant,
with PCNA retained on DNA well into G2/M phase. However
M/G1-ELG1 cells showed less SUMO-PCNA than elg1D at the
75 min time point (cf. Figures 5Bii with 5Bv, and dashed red
with solid blue line in Figure 5C)—consistent with the suggestion
that M/G1-Elg1 can unload residual PCNA from DNA in late M or
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Figure 4. PCNA Modifications Partly Con-
tribute to Abnormal Telomere Elongation
but Not theMMS Sensitivity or Increased Sis-
ter Chromatid Recombination in elg1D
(A) Sensitivity of elg1D to MMS was not rescued by
loss of SUMOylation of PCNA (siz1D pol30-K127R)
or loss of both SUMOylation and ubiquitination of
PCNA (pol30-K127&K164R). 5-fold serial dilutions
of the indicated strains were spotted on YPD me-
dium in the presence or absence of MMS. Plates
were incubated for 2–3 days at 30C.
(B) Increased sister chromatid recombination of
elg1D was rescued neither by loss of SUMOylation
of PCNA (siz1D pol30-K127R) nor by loss of
SUMOylation and ubiquitination of PCNA (pol30-
K127&K164R). Fold increase over wild-type is
shown. Error bars, 95% confidence intervals.
Mann-Whitney; ***p < 0.0001; **p < 0.001.
(C) Abnormal telomere elongation of elg1D was
partly rescued by mutating modification sites of
PCNA (K127R, K164R, or K127R&K164R). Terminal
chromosome fragments were detected by probing
a Southern blot of XhoI-digested genomic DNA for
TG1–3 sequence.G1 phase, to reset PCNA levels before the next round of DNA
replication. In G2/M-ELG1 cells, SUMO-PCNA is over-accumu-
lated in S phase (almost to the same extent as in elg1D), but,
once Elg1 is expressed in G2 phase, SUMO-PCNA disappears
(Figures 5Biv and 5C), consistent with unloading of PCNA by
G2/M-tagged Elg1. To summarize, we successfully established
cell-cycle-regulated alleles of ELG1 that restrict PCNA removal
to M/G1, S, or G2/M phase.
Expression of Elg1 in G2/M Phase Can Rescue the MMS
Sensitivity Observed in elg1D
We used our cell-cycle-regulated ELG1 alleles to examine
whether PCNA retention on DNA at a specific cell-cycle stageFigure 3. Disassembly-Prone Alleles of PCNA Rescue the Increased MMS Sensitivity, Sist
Length of elg1D
(A) Structure of the PCNA trimer (McNally et al., 2010). The positions mutated are highlighted in one of the t
formation).
(B) The trimer interface PCNA mutants do not accumulate on chromatin in elg1D. Whole-cell extracts (WCE)
prepared from cells expressing disassembly-prone PCNAmutants. The disassembly-prone mutants are the
H3 (loading control) were detected by western blotting. 3-fold dilutions of the WT PCNA elg1D sample (1/3
(C) Deletion of ELG1 does not sensitize cells to MMS in the disassembly-prone PCNA mutant backgrou
expressing wild-type PCNA or disassembly-prone PCNA mutants (E143K, D150E or C81R) were spotted
Plates were incubated for 2–3 days at 30C.
(D) Sister chromatid recombination rate of ELG1+ and elg1D in the wild-type and disassembly-prone PCNA
Experimental Procedures. Fold increase over wild-type is shown. Error bars, 95% confidence intervals. Ma
(E) Sister chromatid recombination rate ofSGS1+ and sgs1D in the wild-type and disassembly-prone PCNAm
Error bars, 95% confidence intervals. Mann-Whitney; ***p < 0.0001; *p < 0.05.
(F) Telomere length analysis in wild-type and disassembly-prone PCNA mutant strains (E143K, D150E, or C
chromosome fragments were detected by probing a Southern blot of XhoI-digested genomic DNA for TG1–3
the length of telomeres containing Y’ sequence.
See also Figure S2.
690 Cell Reports 16, 684–695, July 19, 2016causes the genome instability of the
elg1D mutant. Since we already showed
that PCNA accumulation on DNA causes
MMS sensitivity in elg1D, we examinedthe MMS sensitivity of M/G1-, S-, and G2/M-ELG1 cells. M/G1-
ELG1 cells were sensitive to MMS, almost to the same extent
as the elg1D mutant (Figure 5D), indicating that Elg1 expression
in late M and G1 phases is insufficient to rescue the MMS sensi-
tivity.M/G1-ELG1 cells show a slow cell-cycle progression in the
presence of 0.015%MMS, but M/G1-Elg1 still has the chance to
unload PCNA in lateM andG1 phases in the presence of 0.015%
MMS (Figure S3D). These results suggest that removal of PCNA
only in late M and G1 phases is insufficient to rescue the MMS
sensitivity. In contrast, G2/M-ELG1 cells were more resistant to
MMS than M/G1-ELG1 and elg1D (Figure 5D), indicating that
removal of PCNA inG2/Mphase (Figures 5Biv and5C) can largely
prevent the sensitivity to MMS observed in elg1D. These resultser Chromatid Recombination, and Telomere
hree subunits (red: residues important for the trimer
and chromatin-enriched fractions (Chromatin) were
only copy of PCNA in these cells. PCNA and histone
, 1/9, and 1/27) shown for comparison.
nd. 5-fold serial dilutions of ELG1+ or elg1D cells
on YPD medium without or with MMS as indicated.
mutant backgrounds was calculated as described in
nn-Whitney; **p < 0.001; *p < 0.05; n.s., p > 0.05.
utantD150E. Fold increase over wild-type is shown.
81R) in the presence or absence of ELG1. Terminal
sequence. Smeared band at the bottom represents
A C
B D
E
F
Figure 5. PCNA Retention on DNA into G2/M
Phase Causes Sensitivity toMMS, Elongation
of Telomeres, and Increased Sister Chro-
matid Recombination
(A) Schematic of cell-cycle-regulated alleles of
ELG1 that enable restriction of Elg1 to M/G1 (ii),
S (iii), or G2/M (iv) phase. Control with wild-type
ELG1 (i) and elg1D (v) shown for comparison.
(B) Cell-cycle-regulated Elg1 expression and PCNA
removal. Cells were arrested in G1 phase for 4.5 hr
in alpha-factor and released into the cell cycle by
adding pronase. Cells were collected at the indi-
cated time points, and whole-cell extracts were
prepared. Elg1 (i) and M/G1- (ii), S- (iii), or G2/
M-tagged (iv) Elg1 protein in whole-cell extract was
detected by western blot using anti-HA antibody.
PCNA and the mitotic cyclin Clb2 was detected with
anti-PCNA and anti-Clb2 antibodies, respectively.
Asterisk in (iii) indicates degradation products of
S-tagged Elg1. All strains are W303 RAD5+.
(C) Quantification of levels of ‘‘chromatin-bound’’
PCNA. Levels of chromatin-bound PCNA were
estimated from levels of SUMOylated PCNA over
total PCNA shown in (B). Cell-cycle stages assigned
based on times of bud emergence (Figure S3A),
PCNA SUMOylation, and Clb2 expression and
destruction.
(D) Sensitivity to MMS of the cell-cycle-regulated
alleles of ELG1. Plates were incubated for 3 days at
30C. W303 RAD5+ strains.
(E) Telomere length of the cell-cycle-regulated
alleles of ELG1. Terminal chromosome fragments
were detected by probing a Southern blot of XhoI-
digested genomic DNA for TG1–3 sequence. S288c
strains are shown.
(F) Sister chromatid recombination rates of the
cell-cycle-regulated alleles of ELG1. Fold changes,
compared to ELG1+ are shown above. Error bars,
95% confidence intervals. Mann-Whitney; ***p <
0.0001; **p < 0.001. S288c strains carrying the sister
chromatid recombination tester locus were used.
See also Figure S3.suggest that PCNA retention on DNA through G2/M phase
causes MMS sensitivity. PCNA retention on DNA during S phase
causes a mild increase of MMS sensitivity as G2/M-ELG1 cells
are slightly more sensitive than S-ELG1 cells, and somewhat
more sensitive than wild-type ELG1 cells (Figure 5D). S-ELG1
cells exhibited mildly increased sensitivity to MMS compared to
wild-type ELG1 (Figure 5D), probably due to the slight delay in
PCNA unloading (Figures 5Biii and 5C) because of mildly
impaired activity of the tagged Elg1 protein.
The fact that G2/M-ELG1 cells are not particularly MMS sen-
sitive (Figure 5D) suggests that PCNA does not have to be
removed during replication to avoid severe MMS sensitivity,
and that some delay in unloading is compatible with fairly
normal resistance to MMS. These results suggest that the
MMS sensitivity observed in elg1D is primarily the consequence
of retention of PCNA on DNA as cells pass through G2/M
phase.Expression of Elg1 in G2/M Phase Can Partly Rescue
Abnormal Elongation of Telomeres Observed in elg1D
Next, we addressed at which cell-cycle stages expression of
Elg1 can prevent abnormal telomere elongation. Telomere
elongation occurs normally in late S phase, but can still occur
later, in G2/M phase (Diede and Gottschling, 1999). The
abnormal telomere elongation of elg1D was fully rescued in
S-ELG1 cells, and partly rescued in G2/M-ELG1 cells (Fig-
ure 5E). In M/G1-ELG1 cells, however, telomere length was
close to that in elg1D (Figure 5E), indicating that PCNA
removal only at this stage is largely insufficient to prevent inap-
propriate extension by telomerase. Similar tendencies were
observed in a different strain background (Figure S3E). These
results suggest that PCNA retention on DNA during S phase
leads to some inappropriate elongation of telomeres, while
retention through G2/M phase further stimulates the elonga-
tion. This is consistent with the idea that PCNA left onCell Reports 16, 684–695, July 19, 2016 691
telomeres after replication interferes with the pathways moni-
toring telomere length.
The Majority of Increased Sister Chromatid
Recombination Observed in elg1D Is Rescued by
Expression of Elg1 in G2/M Phase
We then addressed at which cell-cycle-stage PCNA accu-
mulation causes increased sister chromatid recombination.
Increased sister chromatid recombination observed in elg1D
was largely rescued in S-ELG1 cells and moderately rescued in
G2/M-ELG1 cells (Figure 5F). M/G1 phase expression of ELG1
also caused some rescue of the elevated sister chromatid
recombination rate of elg1D (Figure 5F), contrasting with the
inability of M/G1-ELG1 to rescue MMS sensitivity and telomere
length. Abnormal sister chromatid recombination is therefore
somewhat stimulated by PCNA accumulation on DNA during
S phase, and progressively further stimulated by PCNA retention
as cells pass through G2/M phase and into G1 phase. The fact
that M/G1-ELG1 cells exhibit only a mild rescue of increased
sister chromatid recombination suggests that the recombination
is stimulated by PCNA retention mainly before or duringM phase
when cells still have paired sister chromatids, but also can be
slightly stimulated by PCNA retention in late M or G1 phase
(see Discussion). Generally, our results imply that the conse-
quences of PCNA retention on DNA emerge primarily in a post-
replicative manner.
Overall, analysis of cell-cycle-regulated alleles reveals that
PCNA retention on DNA beyond DNA replication and into
G2/M phase is the major cause of genome instability of cells
lacking Elg1. While hyper-accumulation of PCNA on DNA during
S phase makes some contribution to the genome instability
phenotypes of the elg1D mutant, the largest contribution to
genome instability results from continued association of PCNA
with DNA into and through G2/M phase.
DISCUSSION
Cells lacking Elg1/ATAD5 exhibit genome instability that leads to
cancer (Bell et al., 2011). We have addressed why loss of yeast
Elg1 causes genome instability and investigated whether the
chromosome maintenance defects result from failure to unload
PCNA. Overexpressing PCNA in cells lead to accumulation of
PCNA on DNA, which caused sensitivity to MMS and exacer-
bated increased sister chromatid recombination rates of elg1D.
In contrast, using disassembly-prone PCNA mutants to relieve
PCNA accumulation on DNA rescued all the phenotypes of
elg1D tested. These results indicate that PCNA accumulation
on DNA is the major cause of genome instability in cells lacking
ELG1. Using a strategy to restrict Elg1 activity to specific cell-
cycle stages, we revealed that prolonged retention of PCNA
on DNA following S phase and through G2/M phase is the
major cause of the genome instability observed in elg1D.
PCNA unloading by Elg1-RLC is therefore critical for genome
maintenance.
Our experiments using ELG1 truncations revealed that MMS
sensitivity generally mirrors failure of PCNA unloading (Figure 1),
consistent with our conclusion that PCNA retention on DNA
causes MMS sensitivity in elg1D. Elg1 216–519, however, ex-692 Cell Reports 16, 684–695, July 19, 2016hibits a slightly increased resistance to MMS (compared to
elg1D carrying empty vector) despite its poor PCNA unloading
activity (Figure 1). This result suggests the possibility that Elg1
plays aminor role inMMS resistance independently of PCNA un-
loading and the formation of the RFC-like complex, potentially
through binding to other proteins such as the Mhf1/Mhf2 his-
tone-like complex that has been reported to bind to the central
domain of Elg1 (235–514 aa) (Singh et al., 2013). Increased sensi-
tivity of Elg1 520–791 to MMS (compared to elg1D carrying
empty vector) might be due to competition for small subunits
Rfc2-5 with other large subunits Ctf18 and Rad24, the lack of
either of which causes increased sensitivity to MMS (Bellaoui
et al., 2003). We also found that the N-terminal domain contain-
ing the SIMs and PCNA interacting peptide (PIP)-like motif
(Parnas et al., 2010) contributes to, but is not essential for
PCNA unloading, and is dispensable for resistance to MMS (Fig-
ure 1). We observed that the central domain of Elg1 can interact
with PCNA (Figure S4), resembling the mode of interaction
between RFC and PCNA (Bowman et al., 2004). We suspect
that Elg1-RLC binds PCNA in a similar manner to RFC, and the
N-terminal domain of Elg1 reinforces the interaction.
To remove PCNA from DNA in elg1D, we utilized disassembly-
prone PCNA mutants that cannot form stable trimers in vitro
(Goellner et al., 2014). Despite the trimer instability, cells ex-
pressing the disassembly-prone mutants grow normally on
YPD without MMS (Figure 3C). It seems likely that these mutants
can form trimers in cells sufficiently well that even if they fall off
DNA, they can be re-loaded at the exposed 30 end of DNA
repeatedly during DNA synthesis, until the DNA ends are ligated
and there is no longer any loading site available. In an elg1D
mutant, PCNA is abnormally retained on DNA even after ligation
of Okazaki fragments has occurred (Kubota et al., 2013b, 2015).
These trimer instability mutants are therefore ideal for stimulating
removal of PCNA in the elg1D context, where with no persisting
Okazaki fragment 30 end they will no longer be re-loaded. For
removing PCNA from DNA in elg1D without affecting other
PCNA functions, the D150E mutant proved the most useful of
those we tested as it shows only modest sensitivity to MMS
and no increase in sister chromatid recombination rate (Figure 3).
In contrast, mutants C81R, V180D, and S115P (known as pol30-
52) showed increased sensitivity to MMS (Figures 3 and S2C),
and the S115Pmutation itself caused increased sister chromatid
recombination (Figures S2D and S2E). The functionality of the
PCNA mutants may depend on how severely their trimer forma-
tion is affected in cells and whether the interaction with PCNA-
binding proteins is compromised.
Why does PCNA retention on DNA cause an increase in MMS
sensitivity and spontaneous sister chromatid recombination?
In cells lacking ELG1, PCNA retention does not seem to impair
Okazaki fragment processing and DNA replication per se (Ku-
bota et al., 2013b; Lee et al., 2013). Instead, we find here that
PCNA retention causes genome instability in G2/M phase of
the cell cycle (Figure 5), suggesting that the consequences of
PCNA retention on DNA emerge in a postreplicative manner,
possibly through the abnormal recruitment of interacting part-
ners that initiate inappropriate repair or recombination-mediated
events. Alternatively, prolonged presence of PCNA itself or its
interacting partners may affect processing of recombination
intermediates, resulting in elevated sister chromatid exchange.
Persistent recombination intermediates could also cause chro-
mosome instability in mitosis (Mankouri et al., 2013). However,
if removal of PCNA from DNA takes place in G2/M phase by
G2/M-ELG1, then these recombination intermediates might
then still be processed properly by proteins such as Sgs1 and
Smc5/6 that can act in G2/M phase (Karras and Jentsch, 2010;
Menolfi et al., 2015), so that G2/M-ELG1 can fairly effectively
rescue genome instability of elg1D.
The increase of sister chromatid recombination that results
from PCNA retention in late M and/or G1 phase (Figure 5F) could
result from recombination intermediates that persist into late
mitosis, causing breakage of catenated DNA and subsequently
double-stranded breaks during the next round of DNA synthesis,
leading in turn to sister chromatid recombination. Alternatively,
PCNA still left on DNA late in the subsequent G1 phase may
interfere with the ensuing round of DNA replication.
Abnormal elongation of telomeres in cells lacking ELG1 is also
caused by PCNA retention on DNA (Figure 3F). Telomere elonga-
tion is known to occur in late S and G2/M phase (Diede and
Gottschling, 1999). We found that removing PCNA from DNA in
G2/M phase using theG2/M-ELG1 allele partly rescued the telo-
mere length defect of elg1D (Figure 5E). This result presumably
reflects that expressing Elg1 during G2/M phase prevents
abnormal extension of telomeres late in the cell cycle, but is
insufficient to prevent elongation that has already occurred in
S phase. We suspect that PCNA retention at the chromosome
ends causes a delay in re-formation of specialized telomeric het-
erochromatin important for inhibiting inappropriate telomere
elongation. Post-translationally modified PCNA may further
hinder the re-formation of telomeric chromatin, which could
explain the partial rescue of abnormal telomere elongation of
elg1D in the unmodifiable PCNA allele. Alternatively, PCNA itself
or PCNA-interacting proteins might stimulate telomere elonga-
tion through an unknown mechanism. Further work is required
to understand howPCNA retention onDNA causes chromosome
instability genome-wide and at telomeres.
It is clear that PCNA association with DNA needs to occur in
the right place at the right time to coordinate the action of
many replisome-associated proteins and repair proteins. Our
results using sophisticated genetics in the model organism
S. cerevisiae reveal that removal of PCNA from DNA by the
Elg1-RLC complex after DNA replication (and possibly during
and after repair) is critical for genome maintenance. Given the
conserved role of the mammalian Elg1 ortholog ATAD5 in
PCNA unloading, it is likely the genome instability and carcino-
genesis associated with loss of ATAD5 is also caused by
PCNA retention on DNA.EXPERIMENTAL PROCEDURES
Plasmid Construction
The plasmids used are listed in Table S1. The plasmids were constructed using
In-fusion Cloning kit (Takara Clontech); see the Supplemental Experimental
Procedures for details of specific plasmid constructions. To construct the
plasmid pTK31 for M/G1 tagging, the PCR fragment containing the Sic1 pro-
moter (688 bp upstream of ATG) and the coding region of the N terminus of
Sic1 (1–105 amino acids) was fused to the plasmid backbone of pRDK1597
(Hombauer et al., 2011) (excluding S-tag) using the In-fusion Cloning kit.Yeast Strains
S. cerevisiae strains used are listed in Table S2. Epitope tagging and gene
disruption were carried out using standard PCR-based gene-insertion
methods (Longtine et al., 1998); see the Supplemental Experimental Proce-
dures for details of specific strain constructions. Yeast strains expressing
PCNA mutants were gifted from the Kolodner lab (Goellner et al., 2014) or
constructed by replacing wild-type PCNA with mutant PCNA (see the Supple-
mental Experimental Procedures). The plasmids pRS303-GALp or pRS303-
GALp-POL30-ADH1t was integrated at the LEU2 locus in a derivative of
DD452 (Kanellis et al., 2003). S-, G2/M-, or M/G1-tag amplified from the plas-
mids pRDK1597, pRDK1598 (Hombauer et al., 2011), or pTK31 was integrated
to the ELG1 locus.
Preparation of Whole-Cell Extracts and Chromatin-Enriched
Fractions and Western Blotting
Whole-cell extracts and chromatin-enriched fractions were prepared as
described previously (Kubota et al., 2015). Western blotting and quantification
were performed as described previously (Kubota et al., 2011). Antibodies used
were mouse monoclonal anti-PCNA (ab70472, Abcam), rabbit polyclonal anti-
histone H3 (ab46765, Abcam), rabbit polyclonal anti-myc (ab9106, Abcam),
mouse monoclonal anti-HA (HA.11 clone 16B12, Covance), and rabbit poly-
clonal anti-Clb2 (y-180, sc-9071, Santa Cruz Biotechnology) antibodies.
Fluctuation Analysis for Sister Chromatid Recombination Rate
The rate (events per cell division) of spontaneous sister chromatid recombina-
tion in the indicated strains was determined by fluctuation analysis (Fasullo
and Davis, 1987; Liefshitz et al., 1995) using the Ma-Sandri-Sarkar (MSS)
maximum-likelihood method (Rosche and Foster, 2000; Sarkar et al., 1992).
Each sister chromatid recombination rate was determined using at least 11
independent cultures. Similarly sized colonies grown 2 days at 30C on YPD
(Figures 3D, 3E, 4B, and 5F), YEP-gal (Figure 2C), or SD-Ura (Figures S2D
and S2E) plates were transferred to 1–2 ml of liquid YPD, YEP-gal, or SD-
Ura and further incubated overnight. After appropriate dilution the cells were
plated on YPD to count viable cells, and SD-His or SD-His-Ura to measure sis-
ter chromatid recombination. Colonies were counted after 3 days. The 95%
confidence intervals were calculated as described previously (Rosche and
Foster, 2000). Mann-Whitney tests were performed to report the two-tailed
p values (http://vassarstats.net/utest.html).
Telomere Length Analysis
Genomic DNA was digested with XhoI, separated on a 1% agarose gel, and
transferred to neutral membrane (MP Biomedicals) by Southern blotting.
Terminal restriction fragments were detected using a probe directed against
the TG repeats.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.06.030.
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